Medtronic partner Sanford advances novel stent; Flextronics and the IoT of medical devices;

@FierceMedDev: IYCMI yesterday: Startup nabs $5.3M to back 2015 launch for connected fertility thermometer, app. Article | Follow @FierceMedDev

@VarunSaxena2: Cannabics Pharma's extended-release medical marijuana capsules available in Colorado. FierceDrugDelivery story | Follow @VarunSaxena2

@EmilyWFierce: Lilly faces patent-infringement fight over 'Take-n-Slide' drug adherence tool. More from FiercePharma | Follow @EmilyWFierce

> Brown University researchers have developed a new measurement tool to more accurately assess dehydration severity in children. More

> Bloomberg featured the electronics manufacturer Flextronics, which is shifting to focus on the Internet-of-Things including medical devices. Story

> Medtronic ($MDT) partner Sanford Health is developing a novel stent design to improve blood flow in patients with thoracoabdominal aneurysms. More

Biotech News

@FierceBiotech: Baxalta bets on 'external innovation' to meet its $8.5B goal and ward off Shire. Article | Follow @FierceBiotech

@JohnCFierce: In a first for diabetes, Lilly and Boehringer's Jardiance prevents heart attacks, strokes in trial. FiercePharma story | Follow @JohnCFierce

@DamianFierce: Turing has a new Form D reflecting that $90M claim but now including warrants and a loan. SEC form | Follow @DamianFierce

> 23andMe brings on Dean Schorno as CFO, operations head. Chutes and Ladders

> Takeda rolls toward EU approval with its heir to Velcade. Article

> Raptor buys into cystic fibrosis with a $418M deal. Item

Pharma News

@FiercePharma: Beef producers lash out at USDA's choice of Humane Society vet for advisory panel. FierceAnimalHealth article | Follow @FiercePharma

@EricPFierce: Mylan recalls more of the cancer meds made at Indian plants hit with FDA warning letter. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Purdue hones abuse-deterrent edge with painkiller safety campaign. FiercePharmaMarketing story | Follow @CarlyHFierce

> Nervous drugmakers await decision on Bass' Ampyra patent challenge. More

> Majority across political spectrum in U.S. favor government steps to cut drug prices. Article